European Leukemia Trial Registry
Trial: AML Relapse SHG

More Details
Short Title AML Relapse SHG
Trialgroup NN
Type of Trial multicentric
Disease Chronic myeloid leukemia(CML) Blast crisis
Acute myeloid leukemia(AML) AML all subtypes without FAB M3
Age >= 18 years
Status Closed
Start of Recruitment 01.01.2001
Leader Bergmann, Prof. Dr. med., Lothar
Centre of Trial Universitätsklinikum Frankfurt
Shortprotocol Shortprotocol
Diagnostics

Floureszenz-In-Situ-Hybridisierung (FISH)
Labor für Leukämieforschung der Medizinischen Hochschule Hannover

created 28.08.2006 Student Studiendatenbank
changed 28.10.2015 Sina Hehn
© ELIC European Leukemia Information Center | no responsibility is taken for correctness and completeness of this information | www.leukemia-net.org | elic@leukemia-net.org